Novel CAR-T therapy shows promising safety and durable responses in hard-to-treat multiple myeloma
A phase 1 clinical trial led by investigators at Mass General Brigham Cancer Institute and the University of Chicago Medicine Comprehensive Cancer Center has found that an investigational CAR-T therapy can lead to deep and ...
Sep 24, 2026
0
51